EGFR and non-small cell lung carcinoma: Regarding EGFR-mutated NSCLC, recent evidence suggests that key miRNAs can deregulate pivotal pathways involved in cell survival, metabolism, epithelial-to-mesenchymal transition (EMT), and apoptosis.